QUOIN PHARMACEUTICALS LT-ADR (QNRX)

US74907L3006 - ADR

0.7763  +0.05 (+6.34%)

After market: 0.7923 +0.02 (+2.06%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
9.38M9.26M6.06M4.07M6.27M
Research and Development
3.31M2.67M1.56M1.71M3.40M
Selling, General, and Administrative Expenses
6.07M6.58M4.50M2.36M2.87M
Operating Income
-9.38M-9.26M-6.06M-4.07M-6.27M
Interest Income/Expense
691.93K-620.00K-1.37M0.001.96M
Other Income/Expense
0.0080.00K-14.03M-1.19M-410.00K
Non Recurring Items
0.00420.00KN/AN/AN/A
Income Before Taxes
-8.69M-9.38M-21.46M-5.26M-4.72M
Income Tax
N/AN/A0.00N/AN/A
Net Income
-8.69M-9.45M-21.46M-5.26M-4.72M
EBITDA
-9.27M-9.16M-5.96M-3.86M-6.04M
 
Per Share Data
EPS Diluted Total Ops
-1.680.00-0.03-0.03-0.58
Non GAAP EPS
-10.24-85.08N/AN/AN/A
 
Statistics

All data in USD

Charts